−3.55USD
−16.423MUSD
969.783KUSD
4.166M
About ABVC BioPharma, Inc.
Sector
CEO
Uttam Yashwant Patil
Headquarters
Fremont
Website
Employees (FY)
23
Founded
1990
ISIN
US00091F3047
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
